Published online before print November 24, 2003, doi: 10.1161/01.HYP.0000103630.72812.10
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;43:10.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
Hypertension Treatment and Control in Five European Countries, Canada, and the United States
From the Department of Preventive Medicine and Epidemiology, Stritch School of Medicine, Loyola University (K.W.-M., R.S.C., H.K.), Maywood, Ill; Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad Autónoma de Madrid (J.R.B.), Madrid, Spain; Instituto Superiore di Sanità, Laboratorio di Epidemiologia e Biostatistica (S.G.), Rome, Italy; the Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University (M.R.J.), Halifax, Nova Scotia, Canada; the Cardiovascular Studies Unit, Imperial College of Science, Technology, and Medicine (N.P.), London, UK; the Department of Epidemiology and Public Health, University College London Medical School (P.P.), London, UK; the Department of Medicine, University Hospital (B.S.), Umeå, Sweden; and the Robert-Koch Institut (M.T.), Berlin, Germany.
Correspondence to Dr Katharina Wolf-Maier, Department of Preventive Medicine and Epidemiology, Stritch School of Medicine, Loyola University, 2160 S First Ave, Maywood, IL 60153. E-mail k.wolf-maier{at}t-online.de
Levels of hypertension treatment and control have been noted to vary between Europe and North America, although direct comparisons with similar methods have not been undertaken. In this study, we sought to estimate the relative impact of hypertension treatment strategies in Germany, Sweden, England, Spain, Italy, Canada, and the United States by using sample surveys conducted in the 1990s. Hypertension was defined as a blood pressure of 160/95 mm Hg or 140/90 mm Hg, plus persons taking antihypertensive medication. "Controlled hypertension" was defined as a blood pressure less than threshold among persons taking antihypertensive medications. Among persons 35 to 64 years, 66% of hypertensives in the United States had their blood pressure controlled at 160/95 mm Hg, compared with 49% in Canada and 23% to 38% in Europe. Similar discrepancies were apparent at the 140/90 mm Hg threshold, at which 29% of hypertensives in the United States, 17% in Canada, and 
10% in European countries had their blood pressure controlled. At the 140/90 mm Hg cutpoint, two thirds to three quarters of the hypertensives in Canada and Europe were untreated compared with slightly less than half in the United States. Although guidelines vary among countries, resulting in different case definitions, this does not account entirely for the varying success of different national control efforts. Low treatment and control rates in Europe, combined with a higher prevalence of hypertension, could contribute to a higher burden of cardiovascular disease risk attributable to elevated blood pressure compared with that in North America.
Key Words: hypertension, detection and control • antihypertensive therapy • blood pressure monitoring • models, statistical • cross-sectional studies
This article has been cited by other articles:
 |
|
 |
|
  A. Rubinstein, L. Alcocer, and A. Chagas High blood pressure in Latin America: a call to action Therapeutic Advances in Cardiovascular Disease, August 1, 2009; 3(4): 259 - 285. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Sever Is systolic blood pressure all that matters? Yes BMJ, July 10, 2009; 339(jul10_1): b2665 - b2665. [Full Text]
|
|
|
|
 |
|
 S. Rinfret, M.-T. Lussier, A. Peirce, F. Duhamel, S. Cossette, L. Lalonde, C. Tremblay, M.-C. Guertin, J. LeLorier, J. Turgeon, et al. The Impact of a Multidisciplinary Information Technology-Supported Program on Blood Pressure Control in Primary Care Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 170 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Falaschetti, M. Chaudhury, J. Mindell, and N. Poulter Continued Improvement in Hypertension Management in England: Results From the Health Survey for England 2006 Hypertension, March 1, 2009; 53(3): 480 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Sarafidis and G. L. Bakris Resistant Hypertension An Overview of Evaluation and Treatment. J. Am. Coll. Cardiol., November 25, 2008; 52(22): 1749 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ashworth, J. Medina, and M. Morgan Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework BMJ, October 28, 2008; 337(oct28_2): a2030 - a2030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fox Benefits of perindopril all along the cardiovascular continuum: the level of evidence Eur. Heart J. Suppl., September 1, 2008; 10(suppl_G): G4 - G12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ingelsson, P. Gona, M. G. Larson, D. M. Lloyd-Jones, W. B. Kannel, R. S. Vasan, and D. Levy Altered Blood Pressure Progression in the Community and Its Relation to Clinical Events Arch Intern Med, July 14, 2008; 168(13): 1450 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Scobie, S. Keyhani, P. L. Hebert, and M. A. McLaughlin Response to Gender and Blood Pressure Control Hypertension, June 1, 2008; 51(6): e49 - e49. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Antonopoulos, S. Kokkoris, S. Gerakari, S. Mikros, T. Nitsotolis, D. Vikeli, P. Korantzopoulos, and G. Giannoulis Comparison of Monotherapy Versus Combination Antihypertensive Therapy in Elderly Patients With Essential Hypertension Angiology, May 1, 2008; 59(2): 230 - 235. [Abstract] [PDF]
|
|
|
|
|
|
J. Ma and R. S. Stafford Screening, Treatment, and Control of Hypertension in US Private Physician Offices, 2003-2004 Hypertension, May 1, 2008; 51(5): 1275 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Rossi, M. Bolognesi, D. Rizzoni, T. M. Seccia, A. Piva, E. Porteri, G. A.M. Tiberio, S. M. Giulini, E. Agabiti-Rosei, and A. C. Pessina Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients Hypertension, May 1, 2008; 51(5): 1366 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Weikert, H. Boeing, T. Pischon, C. Weikert, A. Olsen, A. Tjonneland, K. Overvad, N. Becker, J. Linseisen, A. Trichopoulou, et al. Blood Pressure and Risk of Renal Cell Carcinoma in the European Prospective Investigation into Cancer and Nutrition Am. J. Epidemiol., February 15, 2008; 167(4): 438 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Turchin, M. Shubina, A. H. Chodos, J. S. Einbinder, and M. L. Pendergrass Effect of Board Certification on Antihypertensive Treatment Intensification in Patients With Diabetes Mellitus Circulation, February 5, 2008; 117(5): 623 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Preston, P. Harvey, O. Herfert, G. Dykstra, J. W. Jukema, F. Sun, and D. Gillen A Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial J. Clin. Pharmacol., December 1, 2007; 47(12): 1555 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Addo, L. Smeeth, and D. A. Leon Hypertension In Sub-Saharan Africa: A Systematic Review Hypertension, December 1, 2007; 50(6): 1012 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Qureshi, J. Hatcher, N. Chaturvedi, T. H Jafar, and Hypertension Research Group Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial BMJ, November 17, 2007; 335(7628): 1030 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rieder Getting into a healthy `CV success zone': effective strategies to prevent CVD Eur. Heart J. Suppl., May 1, 2007; 9(suppl_B): B4 - B7. [Full Text] [PDF]
|
|
|
|
|
|
F. J. He and G. A. MacGregor Blood pressure is the most important cause of death and disability in the world Eur. Heart J. Suppl., May 1, 2007; 9(suppl_B): B23 - B28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vaidyanathan, C. Reynolds, C.-M. Yeh, M.-N. Bizot, H. A. Dieterich, D. Howard, and W. P. Dole Pharmacokinetics, Safety, and Tolerability of the Novel Oral Direct Renin Inhibitor Aliskiren in Elderly Healthy Subjects J. Clin. Pharmacol., April 1, 2007; 47(4): 453 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Redon, L. Cea-Calvo, J. V. Lozano, J. C. Marti-Canales, J. L. Llisterri, J. Aznar, J. Gonzalez-Esteban, and on behalf of the investigators of the PREV-ICTUS S Differences in Blood Pressure Control and Stroke Mortality Across Spain: The Prevencion de Riesgo de Ictus (PREV-ICTUS) Study Hypertension, April 1, 2007; 49(4): 799 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Cooper Using Public Health Indicators to Measure the Success of Hypertension Control Hypertension, April 1, 2007; 49(4): 773 - 774. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rienstra, D. J. Van Veldhuisen, H. J.G.M. Crijns, I. C. Van Gelder, and for the RACE investigators Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study Eur. Heart J., March 2, 2007; 28(6): 741 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. R. Wang, G. C. Alexander, and R. S. Stafford Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States Arch Intern Med, January 22, 2007; 167(2): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. R. Wang Lack of Effect of Guideline Changes on Hypertension Control for Patients With Diabetes in the U.S., 1995-2005 Diabetes Care, January 1, 2007; 30(1): 49 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Banegas, J. Segura, J. Sobrino, F. Rodriguez-Artalejo, A. de la Sierra, J. J. de la Cruz, M. Gorostidi, A. Sarria, L. M. Ruilope, and for the Spanish Society of Hypertension Ambulatory Effectiveness of Blood Pressure Control Outside the Medical Setting Hypertension, January 1, 2007; 49(1): 62 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, L. Thijs, and J. A. Staessen Blood Pressure Lowering for Primary and Secondary Prevention of Stroke Hypertension, August 1, 2006; 48(2): 187 - 195. [Full Text] [PDF]
|
|
|
|
 |
|
 F Tuchsen, H Hannerz, C Roepstorff, and N Krause Stroke among male professional drivers in Denmark, 1994-2003 Occup. Environ. Med., July 1, 2006; 63(7): 456 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. John, C. Meyer, M. Hanke, H. Volzke, and A. Schumann Smoking status, obesity and hypertension in a general population sample: a cross-sectional study QJM, June 1, 2006; 99(6): 407 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Poulter Are current therapies for hypertension achieving their goal? Journal of Renin-Angiotensin-Aldosterone System, June 1, 2006; 7(2_suppl): S3 - S6. [Abstract] [PDF]
|
|
|
|
|
|
M. A. James, J. Tullett, A. G. Hemsley, and A. C. Shore Effects of Aging and Hypertension on the Microcirculation Hypertension, May 1, 2006; 47(5): 968 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M Ruilope and A. Zanchetti Targeting Hypertension with Valsartan: Lessons Learned from the Valsartan/HCTZ Versus Amlodipine in Stage II Hypertensive Patients (VAST) Trial Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1_suppl): S8 - S11. [Abstract] [PDF]
|
|
|
|
 |
|
 R. S. Cooper, P. Ordunez, M. D. Iraola Ferrer, J. L. B. Munoz, and A. Espinosa-Brito Cardiovascular Disease and Associated Risk Factors in Cuba: Prospects for Prevention and Control Am J Public Health, January 1, 2006; 96(1): 94 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Grosso, F Veglio, M Porta, F M Grignolo, and T Y Wong Hypertensive retinopathy revisited: some answers, more questions Br J Ophthalmol, December 1, 2005; 89(12): 1646 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wang and R. S. Vasan Epidemiology of Uncontrolled Hypertension in the United States Circulation, September 13, 2005; 112(11): 1651 - 1662. [Full Text] [PDF]
|
|
|
|
|
|
J C. Bakx, M. C van der Wel, and C. van Weel Self monitoring of high blood pressure BMJ, September 3, 2005; 331(7515): 466 - 467. [Full Text] [PDF]
|
|
|
|
|
|
R J McManus, J Mant, A Roalfe, R A Oakes, S Bryan, H M Pattison, and F D R Hobbs Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis BMJ, September 3, 2005; 331(7515): 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. McAlister, E. Wooltorton, N. R.C. Campbell, and for The Canadian Hypertension Education Program The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series Can. Med. Assoc. J., August 30, 2005; 173(5): 508 - 509. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Li, G. Engstrom, B. Hedblad, G. Berglund, and L. Janzon Blood Pressure Control and Risk of Stroke: A Population-Based Prospective Cohort Study Stroke, April 1, 2005; 36(4): 725 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pontremoli, G. Leoncini, F. Viazzi, D. Parodi, V. Vaccaro, V. Falqui, A. Parodi, S. Vettoretti, E. Ratto, and G. Deferrari Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S39 - S41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Maahs, G. L. Kinney, P. Wadwa, J. K. Snell-Bergeon, D. Dabelea, J. Hokanson, J. Ehrlich, S. Garg, R. H. Eckel, and M. J. Rewers Hypertension Prevalence, Awareness, Treatment, and Control in an Adult Type 1 Diabetes Population and a Comparable General Population Diabetes Care, February 1, 2005; 28(2): 301 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lloyd-Jones, E. P. Leip, M. G. Larson, R. S. Vasan, and D. Levy Novel Approach to Examining First Cardiovascular Events After Hypertension Onset Hypertension, January 1, 2005; 45(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sever The VALUE trial: a commentary Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 99 - 101. [Abstract] [PDF]
|
|
|
|
|
|
V. Franco, S. Oparil, and O. A. Carretero Hypertensive Therapy: Part I Circulation, June 22, 2004; 109(24): 2953 - 2958. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Mein, M. J. Caulfield, R. J. Dobson, and P. B. Munroe Genetics of essential hypertension Hum. Mol. Genet., April 1, 2004; 13(90001): R169 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Laurent Guidelines from the British Hypertension Society BMJ, March 13, 2004; 328(7440): 593 - 594. [Full Text] [PDF]
|
|